Molport–Zelencova-Gopejenko D: management, 202409– CEO

	Period	2024-09-01
	Organisation	Molport SIA
	Group	Molport (Group)
	Organisation 2	NN (NO NAME)
	Group	OTHER
	Product	chemical services
	Person	Zelencova-Gopejenko, Diana (Molport 202409– CEO)
	Person 2	Zudans, Imants (Molport 2006–202408 CEO for 17y + Co-Founder STEPPED DOWN 9/24)

Molport Inc.. (9/3/24). "Press Release: Molport Welcomes Diana Zelencova-Gopejenko as CEO". Riga.

New leadership will drive expansion and innovation to improve access to chemical compounds and accelerate global drug discovery and development

Molport Inc., the compound sourcing specialist, announces the appointment of Diana Zelencova-Gopejenko, Ph.D. as CEO, from 2nd September 2024. The appointment replaces co-founder and CEO Imants Zudans, Ph.D. after a 17-year tenure. Under new leadership, Molport plans to both expand its current offering and introduce new, tailored MedChem tools to meet the needs of its customer base.

Zelencova-Gopejenko joins the company as an expert in medicinal chemistry and drug discovery, perfectly placed to deeply understand the needs of chemists and drive innovation of new products and services. In line with Molport’s dedication to prioritizing the diverse chemical compound needs of scientists and researchers, Zelencova-Gopejenko’s unique first-hand experience, fresh approach and future-focused outlook made her the unanimous choice to lead the company in its ongoing mission to turn a complex, fragmented R&D chemical market into an easy-to-access, data-driven marketplace.

She commented, “I am honored to take up the mantle of CEO at Molport. As an expert in medicinal chemistry, my focus will be on enhancing our support for the drug discovery process through innovative solutions. We will expand our chemical space and introduce new services tailored to researcher’s needs, such as customizable data sets, pre-filtered compound libraries, and assay-ready pre-plated formulations. To further accelerate R&D, we will also expand our successful services for the fast-delivery of building blocks, ensuring that our customers have quick access to essential components for the synthesis of new chemical compounds.”

Since 2006, Molport has grown from strength to strength under Zudans’ leadership. The company has developed a unique, intelligent platform that gives users easy access to the global compound marketplace in one place—delivering simpler compound sourcing to millions of scientists worldwide. By connecting over 70 large and, importantly, small suppliers to scientists—alongside transparent information, availability and pricing—this centralized approach unlocks much greater diversity and availability of chemicals, increasing access to these key products. Users of the platform have smart ways to search, order and receive vital compounds for their projects, along with first-class customer support.

Zudans reflected, “Leading Molport has been a journey of daring greatly, growth, and real contribution to accelerating drug discovery. We started this company from scratch and built it into a global leader—I’m so proud of what this exceptionally passionate team has achieved. I'm incredibly grateful to our clients, especially those early believers who stuck with us and shaped our path with their candid feedback. As Diana takes the reins, I have every confidence that Molport will keep doing extraordinary things, keep innovating, and keep delivering the real-world solutions that chemists and drug discovery scientists need to simplify compound purchasing and advance their fields.”

As the company looks to develop its services under new leadership, Zelencova-Gopejenko is keen to reinforce the importance of Molport’s core values—prioritizing customer’s needs, collaboration, integrity and quality—along with the dedication, expertise and collaborative spirit of its people. “It’s a privilege to work alongside such a talented and passionate team” she affirmed. “I’m committed to upholding the core values created by Imants’ unwavering leadership, and to use them as a foundation for this exciting period of growth and development. I’m looking forward to working for, and with, our customers as we create new solutions to help them further their research aims.”

To find out more please visit www.molport.com.

Editor’s notes

Molport

Molport.com is a global trading platform selling over 5.2 million unique chemical stock compounds for research scientists. Molport serves customers worldwide and has a global purchasing network. The company’s clientele includes leading universities, top pharmaceutical companies as well as research institutions and biotech companies. Molport supports chemistry-related research in over 70 countries.

Today, millions of unique chemicals are made by thousands of companies and research institutions worldwide. Most of the chemical compounds remain difficult to locate and buy and therefore are inaccessible to many scientists. Molport has created an easy-to-use marketplace for cost-efficient and centralized ordering of rare chemicals. By using Molport chemical search, ordering, and delivery services, scientists can focus their effort on new discoveries instead of spending valuable time synthesizing chemical compounds that may have already been created elsewhere.

Contacts: Code 2401MOL

Alto Marketing: OMEE AHMED – Senior Manager, Digital & Science Communications; E: omeea@alto-marketing.com; T: +44 (0)2392 004596

Molport: KRISTINE SKULME – Strategic Project Manager; E: Kristine.skulme@molport.com; T: +371 26553653

Record changed: 2024-09-03

Picture Consultech GmbH Secure Funding with RnD Grants 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)